More than 175 companies are scheduled to announce their quarterly financial results on Tuesday. Of particular interest are the following three consumer companies reporting before the market opens.
In Need Of A Better Coach?
Will Coach Inc COH’s earnings continue to fall?
It seems so, as the company is expected to deliver its worst quarter of this decade. The Street is modeling earnings of $0.29 per share on revenue of $972.68 million, while the crowd is projecting earnings of $0.28 per share on revenue of $966.04 million, accordig to Estimize.
These figures compare to EPS of $0.59 on revenue of $1.14 billion reported in the same quarter last year and EPS of $0.36 on sales of $929.3 million retrieved last quarter.
It should be noted from the chart above, however, that Coach has managed to surpass estimates in the last five consecutive quarters. So, a beat could be expected without being too far-fetched.
Healthy Results
CVS Health Corp CVS will also announce its second-quarter financial results on Tuesday morning. Opposite of its retail peer, Coach, CVS is expected to report one of – if not the – strongest quarters ever.
Management guided EPS of $1.19, while the Street anticipates earnings of $1.20 per share on revenue of $37.156 billion. The crowd is, nonetheless, the most bullish, projecting earnings of $1.22 per share on sales of $37.26 billion.
These estimates compare with earnings of $1.13 per share, revenue of $34.602 billion reported in the second quarter of 2014 and earnings of $1.14 per share on revenue of $36.332 billion retrieved last quarter.
The Not-So-Special K
Finally, there’s the Kellogg Company K, which is expected to deliver EPS between $0.91 (the Street’s consensus) and $0.93 (the crowd’s consensus) on revenue in the range of $3.45 billion (crowd) to $3.473 billion (Street).
As the chart above demonstrates, these results are far from special. In fact, they would imply a double-digit decline from the earnings of $1.02 per share (on revenue of $3.685 billion) reported a year ago and from the EPS of $0.98 (on sales of $3.556 billion) registered last quarter.
Image Credit: Public Domain© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
